CD36 and TLR interactions in inflammation and phagocytosis: Implications for malaria

Journal of Immunology

Volumn 183, Issue 10, 2009, Pages 6452-6459

  Erdman, Laura K ^a,b   Cosio, Gabriela ^a,c   Helmers, Andrew J ^d   Gowda, D Channe ^e   Grinstein, Sergio ^a,b,c   Kain, Kevin C ^a,b,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

^f TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOCYTOSIS; HUMAN; HUMAN CELL; INFLAMMATION; INTERNALIZATION; MACROPHAGE; MALARIA; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD36; CYTOKINES; DIGLYCERIDES; ERYTHROCYTES; HUMANS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LIPOPEPTIDES; MACROPHAGES; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGOPEPTIDES; PHAGOCYTOSIS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; TOLL-LIKE RECEPTOR 2;

EID: 77954231911     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901374     Document Type: Article

References (55)

1. Febbraio, M., D. P. Hajjar, and R. L. Silverstein. 2001. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108: 785-791.
2. Koenigsknecht, J., and G. Landreth. 2004. Microglial phagocytosis of fibrillar β-amyloid through a β1 integrin-dependent mechanism. J. Neurosci. 24: 9838-9846.
3. Endemann, G., L. W. Stanton, K. S. Madden, C. M. Bryant, R. T. White, and A. A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268: 11811-11816. (Pubitemid 23168135)
4. Baranova, I. N., R. Kurlander, A. V. Bocharov, T. G. Vishnyakova, Z. Chen, A. T. Remaley, G. Csako, A. P. Patterson, and T. L. Eggerman. 2008. Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J. Immunol. 181: 7147-7156.
5. Fadok, V. A., M. L. Warner, D. L. Bratton, and P. M. Henson. 1998. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (α v β 3). J. Immunol. 161: 6250-6257.
6. McGilvray, I. D., L. Serghides, A. Kapus, O. D. Rotstein, and K. C. Kain. 2000. Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. Blood 96: 3231-3240.
7. Moore, K. J., J. El Khoury, L. A. Medeiros, K. Terada, C. Geula, A. D. Luster, and M. W. Freeman. 2002. A CD36-initiated signaling cascade mediates inflammatory effects of β-amyloid. J. Biol. Chem. 277: 47373-47379.
8. Stuart, L. M., J. Deng, J. M. Silver, K. Takahashi, A. A. Tseng, E. J. Hennessy, R. A. Ezekowitz, and K. J. Moore. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170: 477-485.
9. Maxeiner, H., J. Husemann, C. A. Thomas, J. D. Loike, J. El Khoury, and S. C. Silverstein. 1998. Complementary roles for scavenger receptor A and CD36 of human monocyte-derived macrophages in adhesion to surfaces coated with oxidized low-density lipoproteins and in secretion of H2O2. J. Exp. Med. 188: 2257-2265.
10. Janabi, M., S. Yamashita, K. Hirano, N. Sakai, H. Hiraoka, K. Matsumoto, Z. Zhang, S. Nozaki, and Y. Matsuzawa. 2000. Oxidized LDL-induced NF-κB activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler. Thromb. Vasc. Biol. 20: 1953-1960.
11. 2, and PAF. J. Clin. Invest. 101: 890-898.
12. Voll, R. E., M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite. 1997. Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
13. Hoebe, K., P. Georgel, S. Rutschmann, X. Du, S. Mudd, K. Crozat, S. Sovath, L. Shamel, T. Hartung, U. Zahringer, and B. Beutler. 2005. CD36 is a sensor of diacylglycerides. Nature 433: 523-527.
14. Triantafilou, M., F. G. Gamper, R. M. Haston, M. A. Mouratis, S. Morath, T. Hartung, and K. Triantafilou. 2006. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 281: 31002-31011.
15. Underhill, D. M., and B. Gantner. 2004. Integration of Toll-like receptor and phagocytic signaling for tailored immunity. Microbes Infect. 6: 1368-1373.
16. Blander, J. M., and R. Medzhitov. 2004. Regulation of phagosome maturation by signals from toll-like receptors. Science 304: 1014-1018.
17. Doyle, S. E., R. M. O'Connell, G. A. Miranda, S. A. Vaidya, E. K. Chow, P. T. Liu, S. Suzuki, N. Suzuki, R. L. Modlin, W. C. Yeh, et al. 2004. Toll-like receptors induce a phagocytic gene program through p38. J. Exp. Med. 199: 81-90.
18. Hajishengallis, G., M. Wang, E. Harokopakis, M. Triantafilou, and K. Triantafilou. 2006. Porphyromonas gingivalis fimbriae proactively modulate β2 integrin adhesive activity and promote binding to and internalization by macrophages. Infect. Immun. 74: 5658-5666.
19. Parroche, P., F. N. Lauw, N. Goutagny, E. Latz, B. G. Monks, A. Visintin, K. A. Halmen, M. Lamphier, M. Olivier, D. C. Bartholomeu, et al. 2007. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl. Acad. Sci. USA 104: 1919-1924.
20. Furuta, T., S. Imajo-Ohmi, H. Fukuda, S. Kano, K. Miyake, and N. Watanabe. 2008. Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin. Eur. J. Immunol. 38: 1341-1350.
21. Krishnegowda, G., A. M. Hajjar, J. Zhu, E. J. Douglass, S. Uematsu, S. Akira, A. S. Woods, and D. C. Gowda. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J. Biol. Chem. 280: 8606-8616.
22. Gowda, D. C. 2007. TLR-mediated cell signaling by malaria GPIs. Trends Parasitol. 23: 596-604.
23. Patel, S. N., L. Serghides, T. G. Smith, M. Febbraio, R. L. Silverstein, T. W. Kurtz, M. Pravenec, and K. C. Kain. 2004. CD36 mediates the phagocytosis of Plasmodium falciparum-infected erythrocytes by rodent macrophages. J. Infect. Dis. 189: 204-213.
24. Braun-Breton, C., T. L. Rosenberry, and L. P. da Silva. 1988. Induction of the proteolytic activity of a membrane protein in Plasmodium falciparum by phosphatidyl inositol-specific phospholipase C. Nature 332: 457-459.
25. Hoffmann, P. R., A. M. deCathelineau, C. A. Ogden, Y. Leverrier, D. L. Bratton, D. L. Daleke, A. J. Ridley, V. A. Fadok, and P. M. Henson. 2001. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155: 649-659.
26. Vachon, E., R. Martin, J. Plumb, V. Kwok, R. W. Vandivier, M. Glogauer, A. Kapus, X. Wang, C. W. Chow, S. Grinstein, and G. P. Downey. 2006. CD44 is a phagocytic receptor. Blood 107: 4149-4158.
27. Komatsu, N., K. Kirito, R. Shimizu, M. Kunitama, M. Yamada, M. Uchida, M. Takatoku, M. Eguchi, and Y. Miura. 1997. In vitro development of erythroid and megakaryocytic cells from a UT-7 subline, UT-7/GM. Blood 89: 4021-4033.
28. Patel, S. N., Z. Lu, K. Ayi, L. Serghides, D. C. Gowda, and K. C. Kain. 2007. Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo. J. Immunol. 178: 3954-3961.
29. Booth, J. W., M. K. Kim, A. Jankowski, A. D. Schreiber, and S. Grinstein. 2002. Contrasting requirements for ubiquitylation during Fc receptor-mediated endocytosis and phagocytosis. EMBO J. 21: 251-258.
30. Huang, Z. Y., D. R. Barreda, R. G. Worth, Z. K. Indik, M. K. Kim, P. Chien, and A. D. Schreiber. 2006. Differential kinase requirements in human and mouse Fc-γ receptor phagocytosis and endocytosis. J. Leukocyte Biol. 80: 1553-1562.
31. Means, T. K., E. Mylonakis, E. Tampakakis, R. A. Colvin, E. Seung, L. Puckett, M. F. Tai, C. R. Stewart, R. Pukkila-Worley, S. E. Hickman, et al. 2009. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J. Exp. Med. 206: 637-653.
32. Mae, M., M. Iyori, M. Yasuda, H. M. Shamsul, H. Kataoka, K. Kiura, A. Hasebe, Y. Totsuka, and K. Shibata. 2007. The diacylated lipopeptide FSL-1 enhances phagocytosis of bacteria by macrophages through a Toll-like receptor 2-mediated signalling pathway. FEMS Immunol. Med. Microbiol. 49: 398-409.
33. Scragg, I. G., M. Hensmann, C. A. Bate, and D. Kwiatkowski. 1999. Early cytokine induction by Plasmodium falciparum is not a classical endotoxin-like process. Eur. J. Immunol. 29: 2636-2644.
34. Artavanis-Tsakonas, K., J. E. Tongren, and E. M. Riley. 2003. The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin. Exp. Immunol. 133: 145-152.
35. Hu, X., S. D. Chakravarty, and L. B. Ivashkiv. 2008. Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 226: 41-56.
36. Jana, M., C. A. Palencia, and K. Pahan. 2008. Fibrillar amyloid-β peptides activate microglia via TLR2: implications for Alzheimer's disease. J. Immunol. 181: 7254-7262.
37. Miller, Y. I., M. K. Chang, C. J. Binder, P. X. Shaw, and J. L. Witztum. 2003. Oxidized low density lipoprotein and innate immune receptors. Curr. Opin. Lipidol. 14: 437-445.
38. Schuepp, B. J., H. Pfister, K. J. Clemetson, R. L. Silverstein, and T. W. Jungi. 1991. CD36-mediated signal transduction in human monocytes by anti-CD36 antibodies but not by anti-thrombospondin antibodies recognizing cell membrane-bound thrombospondin. Biochem. Biophys. Res. Commun. 175: 263-270.
39. West, M. A., R. P. Wallin, S. P. Matthews, H. G. Svensson, R. Zaru, H. G. Ljunggren, A. R. Prescott, and C. Watts. 2004. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 305: 1153-1157.
40. Arbibe, L., J. P. Mira, N. Teusch, L. Kline, M. Guha, N. Mackman, P. J. Godowski, R. J. Ulevitch, and U. G. Knaus. 2000. Toll-like receptor 2-mediated NF-κB activation requires a Rac1-dependent pathway. Nat. Immunol. 1: 533-540.
41. Kong, L., and B. X. Ge. 2008. MyD88-independent activation of a novel actin-Cdc42/Rac pathway is required for Toll-like receptor-stimulated phagocytosis. Cell Res. 18: 745-755.
42. Richard, K. L., M. Filali, P. Prefontaine, and S. Rivest. 2008. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid β1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J. Neurosci. 28: 5784-5793.
43. Baruch, D. I., X. C. Ma, H. B. Singh, X. Bi, B. L. Pasloske, and R. J. Howard. 1997. Identification of a region of PfEMP1 that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: conserved function with variant sequence. Blood 90: 3766-3775.
44. Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811-815. (Pubitemid 129515844)
45. Ozinsky, A., D. M. Underhill, J. D. Fontenot, A. M. Hajjar, K. D. Smith, C. B. Wilson, L. Schroeder, and A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA 97: 13766-13771.
46. Chieppa, M., G. Bianchi, A. Doni, A. Del Prete, M. Sironi, G. Laskarin, P. Monti, L. Piemonti, A. Biondi, A. Mantovani, et al. 2003. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J. Immunol. 171: 4552-4560.
47. Underhill, D. M., and A. Ozinsky. 2002. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20: 825-852.
48. Hunt, N. H., and G. E. Grau. 2003. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 24: 491-499.
49. Coban, C., K. J. Ishii, T. Horii, and S. Akira. 2007. Manipulation of host innate immune responses by the malaria parasite. Trends Microbiol. 15: 271-278.
50. Ropert, C., B. S. Franklin, and R. T. Gazzinelli. 2008. Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria. Semin. Immunopathol. 30: 41-51.
51. Quinn, T. C., and D. J. Wyler. 1979. Intravascular clearance of parasitized erythrocytes in rodent malaria. J. Clin. Invest. 63: 1187-1194.
52. Smith, L. P., K. W. Hunter, E. C. Oldfield, and G. T. Strickland. 1982. Murine malaria: blood clearance and organ sequestration of Plasmodium yoelii-infected erythrocytes. Infect. Immun. 38: 162-167.
53. Bach, O., M. Baier, A. Pullwitt, N. Fosiko, G. Chagaluka, M. Kalima, W. Pfister, E. Straube, and M. Molyneux. 2005. Falciparum malaria after splenectomy: a prospective controlled study of 33 previously splenectomized Malawian adults. Trans. R Soc. Trop. Med. Hyg. 99: 861-867.
54. Demar, M., E. Legrand, D. Hommel, P. Esterre, and B. Carme. 2004. Plasmodium falciparum malaria in splenectomized patients: two case reports in French Guiana and a literature review. Am. J. Trop. Med. Hyg. 71: 290-293. (Pubitemid 39223504)
55. Su, Z., A. Fortin, P. Gros, and M. M. Stevenson. 2002. Opsonin-independent phagocytosis: an effector mechanism against acute blood-stage Plasmodium chabaudi AS infection. J. Infect. Dis. 186: 1321-1329.